SCHEMBL2156279

SCHEMBL2156279

COC(=O)Cn1c(-c2ccccc2C=O)c(C2CCCCC2)c2sc(C(=O)OC)cc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.34
KDM4E B2RXH2 4/20 0.33
ALDH1A1 P00352 3/20 0.33
TSHR P16473 3/20 0.33
HPGD P15428 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
HSD17B10 Q99714 2/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
MAPK1 P28482 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
ATM Q13315 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MAPT P10636 2/20 0.33
CDK1 P06493 1/20 0.33
KMT2A Q03164 1/20 0.32
CCNT1 O60563 1/20 0.32
CDK9 P50750 1/20 0.32
NR1H4 Q96RI1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2157328 0.93 KDM4E (0.31) CYP2D6KDM4ETSHRHSD17B10SMN1; SMN2
SCHEMBL2162790 0.88 KDM4E (0.32) CYP2D6KDM4EALDH1A1TSHRHPGD
SCHEMBL2156465 0.85 KDM4E (0.34) KDM4ETSHRHSD17B10KMT2A
SCHEMBL2156720 0.83 KDM4E (0.37) KDM4EALDH1A1TSHRHPGDL3MBTL1
SCHEMBL2156333 0.83 ALDH1A1 (0.38) KDM4EALDH1A1TSHRHPGDL3MBTL1
SCHEMBL2156282 0.82 ALDH1A1 (0.37) KDM4EALDH1A1TSHRHPGDL3MBTL1
SCHEMBL2157396 0.79 NR1I3 (0.34) KDM4EALDH1A1HPGDL3MBTL1
SCHEMBL2994392 0.79 KDM4E (0.40) KDM4EALDH1A1HPGDATMSMN1; SMN2
SCHEMBL2998707 0.79 KDM4E (0.36) KDM4EALDH1A1ATMSMN1; SMN2MAPT
SCHEMBL2157156 0.79 KDM4E (0.35) CYP2D6KDM4EALDH1A1TSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973026-B2 Thienopyrroles as antiviral agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2011-07-05 US disclosed
US-20090105227-A1 Thienopyrroles As Antiviral Agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2009-04-23 US disclosed
EP-1881989-A1 THIENOPYRROLES AS ANTIVIRAL AGENTS Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. (IT) 2008-01-30 EP disclosed
WO-2006119975-A1 THIENOPYRROLES AS ANTIVIRAL AGENTS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2006-11-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105227-A1 Thienopyrroles As Antiviral Agents ZC3HAV1, HAVCR2, ZC3HAV1L CYP2D6 71/4885KDM4E 3275/4885ALDH1A1 433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.